BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 141980)

  • 1. Radioimmunoassays for methotrexate, citrovorum factor, neocarzinostatin, and actinomycin D.
    Raso V
    Cancer Treat Rep; 1977 Jul; 61(4):585-90. PubMed ID: 141980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and specific radioimmunoassay for methotrexate.
    Raso V; Schreiber R
    Cancer Res; 1975 Jun; 35(6):1407-10. PubMed ID: 1079473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of neocarzinostatin, an antitumor protein.
    Samy TS; Raso V
    Cancer Res; 1976 Dec; 36(12):4378-81. PubMed ID: 63321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neocarzinostatin: carboxyl-terminal-43-peptide residue of apo-neocarzinostatin as the binding site of neocarzinostatin-chromophore.
    Edo K; Saito K; Akiyama Y; Mizugaki M; Koide Y; Ishida N
    Chem Pharm Bull (Tokyo); 1986 Dec; 34(12):5180-3. PubMed ID: 2952300
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorophotometric enzyme immunoassay of neocarzinostatin using peroxidase as a label.
    Matsuoka K; Maeda M; Tsuji A
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1864-8. PubMed ID: 6447549
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioimmunoassay of methotrexate, leucovorin, and 5-methyltetrahydrofolate.
    Langone JJ
    Methods Enzymol; 1982; 84():409-22. PubMed ID: 6980360
    [No Abstract]   [Full Text] [Related]  

  • 7. Extra-weak chemiluminescence of drugs. IX. Extra-weak chemiluminescence of neocarzinostatin injection.
    Edo K; Saito K; Kato M; Akiyama-Murai Y; Sato H; Mizugaki M
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4603-7. PubMed ID: 2977573
    [No Abstract]   [Full Text] [Related]  

  • 8. Naphthalenecarboxylic acid from neocarzinostatin (NCS).
    Edo K; Katamine S; Kitame F; Ishida N; Koide Y; Kusano G; Nozoe S
    J Antibiot (Tokyo); 1980 Mar; 33(3):347-51. PubMed ID: 6445890
    [No Abstract]   [Full Text] [Related]  

  • 9. A radioimmunoassay for methotrexate and its comparison with spectrofluorimetric procedures.
    Loeffler LJ; Blum MR; Nelsen MA
    Cancer Res; 1976 Sep; 36(9 pt.1):3306-11. PubMed ID: 1086132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of a free chromophore component of neocarzinostatin (NCS) in the culture filtrate of Streptomyces carzinostaticus var. F-41.
    Kudo K; Suto T; Koide Y; Edo K; Ishida N
    J Antibiot (Tokyo); 1982 Aug; 35(8):1111-5. PubMed ID: 6216232
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of a non-protein component and a protein component from neocarzinostatin (NCS) and their biological activities.
    Koide Y; Ishii F; Hasuda K; Koyama Y; Edo K; Kitamine S; Kitame F; Ishida N
    J Antibiot (Tokyo); 1980 Mar; 33(3):342-6. PubMed ID: 6445889
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme immunoassay of neocarzinostatin using beta-galactosidase as label.
    Tanimori H; Kitagawa T; Tsunoda T; Tsuchiya R
    J Pharmacobiodyn; 1981 Oct; 4(10):812-9. PubMed ID: 6459444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay for methotrexate.
    Levine L; Powers E
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):543-54. PubMed ID: 4548552
    [No Abstract]   [Full Text] [Related]  

  • 14. Assay for methotrexate in nanomolar concentrations with simultaneous detection of citrovorum factor and vincristine.
    Deen WM; Levy PF; Wei J; Partridge RD
    Anal Biochem; 1981 Jul; 114(2):355-61. PubMed ID: 6975584
    [No Abstract]   [Full Text] [Related]  

  • 15. Urea treatment and pronase digestion of antitumor protein antibiotics, auromomycin and neocarzinostatin.
    Suzuki H; Ozawa S; Tanaka N
    J Antibiot (Tokyo); 1980 Dec; 33(12):1545-50. PubMed ID: 6454671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay for citrovorum factor (NSC-3590) in the presence of methotrexate (NSC-740).
    Mehta BM; Hutchison DJ
    Cancer Chemother Rep; 1975; 59(5):935-7. PubMed ID: 1081908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of secondary structure of neocarzinostatin apoprotein.
    Saito K; Sato Y; Edo K; Akiyama-Murai Y; Koide Y; Ishida N; Mizugaki M
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3078-82. PubMed ID: 2534360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of radioimmunoassays to determine the concentration of streptococcal group-specific antibodies in rabbit antisera.
    Bernstein D; Klapper DG; Krause RM
    J Immunol; 1975 Jan; 114(1 Pt 1):59-63. PubMed ID: 1112976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an antibody to actinomycin D and its application for the detection of serum levels by radioimmunoassay.
    Brothman AR; Davis TP; Duffy JJ; Lindell TJ
    Cancer Res; 1982 Mar; 42(3):1184-7. PubMed ID: 6174214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiologic assays of cancer chemotherapeutic agents.
    Mehta BM; Hutchison DJ
    Cancer Treat Rep; 1977 Jul; 61(4):597-601. PubMed ID: 406993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.